OS Therapies Incorporated (OSTX) Stock

Healthcare · Biotechnology · Member of Other US Stocks

OS Therapies Incorporated (OSTX) closed at USD 1.39 on 2026-10-14, a change of -25.7 % over the past year, with a market capitalization of USD 66M.

OS Therapies Incorporated recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

OS Therapies Incorporated key figures

Previous close

USD 1.39 (2026-10-14)

1-year change

-25.7 %

Market cap

USD 66M

Enterprise value

USD 65.9M

P/E ratio (trailing)

-1.34

P/E ratio (forward)

4.07

EPS (trailing)

-1.05

EPS (forward)

0.35

PEG ratio

n/a

Price to book

-5.36

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

3.57

Employees

4

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About OS Therapies Incorporated

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for OS Therapies Incorporated and compare it with other stocks.